Not applicableStudy completedNCT00797602What this trial is testingProton Therapy for Chordomas and/or ChondrosarcomasWho this might be right forChordomasChondrosarcomas University of Florida 189
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743554What this trial is testingCombination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath TumorWho this might be right forMPNST (Malignant Peripheral Nerve Sheath Tumor) Girish Dhall, MD 23
Testing effectiveness (Phase 2)WithdrawnNCT05854966What this trial is testingCPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia RefractoryGranulocytic Sarcoma Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Active Not RecruitingNCT03367741What this trial is testingCabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial CancerWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more National Cancer Institute (NCI) 82
Not applicableStudy completedNCT01624220What this trial is testingA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyWho this might be right forSpinal Tumor M.D. Anderson Cancer Center 41
Early research (Phase 1)UnknownNCT03775525What this trial is testingStudy Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerWho this might be right forAdvanced CancerGastric CancerBreast Cancer+14 more Genzada Pharmaceuticals USA, Inc. 127
Early research (Phase 1)Looking for participantsNCT07229313What this trial is testingKIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvance Solid Tumors Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)UnknownNCT03815474What this trial is testingAnlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma PatientsWho this might be right forSarcoma, Soft Tissue Liaoning Cancer Hospital & Institute 47
Testing effectiveness (Phase 2)Looking for participantsNCT04616560What this trial is testingTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorWho this might be right forDesmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)UnknownNCT00033709What this trial is testingTemozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaWho this might be right forSarcoma Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03277924What this trial is testingTrial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasWho this might be right forSoft Tissue SarcomaBone Sarcoma Grupo Espanol de Investigacion en Sarcomas 197
Testing effectiveness (Phase 2)Active Not RecruitingNCT03373097What this trial is testingAnti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid TumorsWho this might be right forNeuroblastomaNeuroblastoma RecurrentGD2-positive Solid Tumors+3 more Bambino Gesù Hospital and Research Institute 42
Not applicableStudy completedNCT06216990What this trial is testingMetastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and SafetyWho this might be right forSarcomaSoft Tissue Sarcoma Centre Hospitalier Universitaire de Besancon 60
Post-approval studies (Phase 4)Ended earlyNCT00924950What this trial is testingTaclonex Ointment With Hydrogel Patch Occlusion for the Treatment of PsoriasisWho this might be right forPlaque PsoriasisPsoriasis Vulgaris University of California, San Francisco 35
Early research (Phase 1)Study completedNCT01495663What this trial is testingDose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedWho this might be right forCancer Cellectar Biosciences, Inc. 12
Early research (Phase 1)Study completedNCT00629343What this trial is testingPhase I Dose-Escalation Study Of Azacitidine In Combination With TemozolomideWho this might be right forSoft Tissue SarcomaMesothelioma Columbia University 27
Testing effectiveness (Phase 2)Study completedNCT00023725What this trial is testingRadiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue SarcomaWho this might be right forSarcoma Radiation Therapy Oncology Group
Not applicableActive Not RecruitingNCT04671693What this trial is testingA Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Who this might be right forLate EffectsTesticular Germ Cell Tumor MixedNon-Metastatic Breast Carcinoma+6 more Centre Leon Berard 500
Testing effectiveness (Phase 2)Ended earlyNCT02259348What this trial is testingRepeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationWho this might be right forAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT05275478What this trial is testingSafety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsWho this might be right forLocally Advanced Solid Tumor Tango Therapeutics, Inc. 110